- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00599040
The DINE Study-Diet Intervention to Negate Diabetes Study (Improving Weight Loss Outcomes for African Americans) (DINE)
March 15, 2013 updated by: Jamy Ard, MD, University of Alabama at Birmingham
The purpose of this study is to determine if what you eat affets your insulin sensitivity when you lose a small amount of weight
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
113
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35294
- University of Alabama at Birmingham Nutrition Sciences Department
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- African American adults (age ≥ 19)
- Obese (BMI > or equal to 30 kg/m2)
- Otherwise generally healthy
Exclusion Criteria:
- Diagnoses of diabetes
- Malignancy or other states where weight loss is contraindicated (pregnancy
- Individuals with high blood pressure on medications.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Weight loss
Weight loss diet focused on the DASH diet
|
A reduced calorie diet is provided to participants based on the DASH diet.
|
|
Active Comparator: DASH diet
The DASH diet without weight loss
|
participants are given a weight maintainenance diet based on the DASH diet
|
|
Active Comparator: Diary
Dairy Intervention
|
participants are given a high dairy, reduced calorie diet
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Insulin Sensitivity
Time Frame: 8 weeks
|
8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2005
Primary Completion (Actual)
December 1, 2009
Study Completion (Actual)
December 1, 2010
Study Registration Dates
First Submitted
January 10, 2008
First Submitted That Met QC Criteria
January 22, 2008
First Posted (Estimate)
January 23, 2008
Study Record Updates
Last Update Posted (Estimate)
March 18, 2013
Last Update Submitted That Met QC Criteria
March 15, 2013
Last Verified
March 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- F040719005
- 1K23DK068223-01 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
Clinical Trials on The DASH diet with weight loss
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedHypertensionUnited States
-
Instituto Aragones de Ciencias de la SaludCompletedObesity | Overweight | Weight Loss | Diet, Reducing | Lipids
-
Johns Hopkins UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedObesity | Overweight | Type 2 Diabetes | PrediabetesUnited States
-
Instituto Aragones de Ciencias de la SaludUnknownObesity | Diabetes | Weight Loss | Protein | Diet, Reducing | CarbohydratesSpain
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompleted
-
Colorado State UniversityCompleted
-
Centro Studi GisedAzienda Ospedaliero-Universitaria di ModenaCompleted
-
University of Tennessee Health Science CenterRecruiting
-
Hacettepe UniversityRecruitingObesity | Polymorphism, Restriction Fragment LengthTurkey
-
Queen's UniversityCanadian Institutes of Health Research (CIHR)Completed